Company | Date | Price Target | Rating | Analyst |
---|---|---|---|---|
7/11/2024 | Mkt Perform | Raymond James | ||
4/26/2024 | $35.00 → $41.00 | Neutral → Overweight | Piper Sandler | |
2/5/2024 | $36.00 | Neutral → Buy | Citigroup | |
1/2/2024 | $38.00 → $40.00 | Overweight → Equal Weight | Barclays | |
12/4/2023 | $31.00 | Overweight → Equal-Weight | Morgan Stanley | |
10/25/2023 | $29.00 → $26.00 | Overweight → Neutral | Piper Sandler | |
10/23/2023 | Underperform → Peer Perform | Wolfe Research | ||
7/10/2023 | $32.00 → $29.00 | Outperform → In-line | Evercore ISI |
Rankings Highlight Exceptional, Under-the-Radar Schools Across the Nation College Raptor, Citizens' college planning platform and the most comprehensive college search site, today released its tenth annual "Hidden Gem" rankings, an unmatched list spotlighting excellent, yet lesser-known schools by state and region. The 2025 rankings also include top colleges for in-demand programs, such as AI and Nursing, representing two of today's fastest-growing and most sought-after career paths. Hidden Gem rankings shine a light on the highest-rated schools in College Raptor's directory that are more accessible institutions with strong academic excellence but tend to have a lower application volume.
Citizens Financial Group, Inc. (NYSE:CFG) announced today that Citizens Bank, N.A. has decreased its prime lending rate to 8.00 percent from 8.50 percent, effective Thursday, September 19, 2024. About Citizens Financial Group, Inc. Citizens Financial Group, Inc. is one of the nation's oldest and largest financial institutions, with $219.9 billion in assets as of June 30, 2024. Headquartered in Providence, Rhode Island, Citizens offers a broad range of retail and commercial banking products and services to individuals, small businesses, middle-market companies, large corporations and institutions. Citizens helps its customers reach their potential by listening to them and by understanding t
Initiative Aims to Strengthen Talent Pipelines and Drive Economic Growth Across Citizens Footprint Citizens announced today a commitment to provide $10 million over the next two years to support workforce development programs. Funding will support nonprofits working to enhance and expand access to educational and career opportunities, address the rapidly changing demands of the modern economy, and support long-term economic growth. "Workforce development is a major focus for the bank and one that is top of mind for our clients and critical to the success of the communities we serve," said Bruce Van Saun, Chairman & CEO of Citizens. "This investment is not just about supporting programs, i
SC 13G/A - CITIZENS FINANCIAL GROUP INC/RI (0000759944) (Subject)
SC 13G/A - Arcus Biosciences, Inc. (0001724521) (Subject)
SC 13G - CITIZENS FINANCIAL GROUP INC/RI (0000759944) (Subject)
8-K - CITIZENS FINANCIAL GROUP INC/RI (0000759944) (Filer)
8-K - Arcus Biosciences, Inc. (0001724521) (Filer)
13F-HR - CITIZENS FINANCIAL GROUP INC/RI (0000759944) (Filer)
Today, Citizens Financial Group (NYSE:CFG) announced that it has appointed Christopher Schnirel as Controller and Chief Accounting Officer, effective October 21, 2024. "We are pleased to welcome Chris to Citizens, where he will play a key role in maintaining a high standard of excellence in financial reporting and controls as well as supporting our strategic agenda," said John Woods, Vice Chair and Chief Financial Officer. "He brings great expertise and over 20 years of strong leadership experience in financial services." Schnirel, most recently was the Senior Vice President and Assistant Controller at Huntington Bancshares Inc., where he led SEC reporting, regulatory reporting, accountin
Citizens Financial Group, Inc. (NYSE:CFG) today announced that Don McCree, Head of Commercial Banking, has been appointed as Senior Vice Chair of Citizens. Chairman and CEO Bruce Van Saun commented: "This appointment recognizes Don's strong performance and leadership since 2015 in driving the successful buildout of our Commercial Bank and instilling a strong customer-focused, collaborative culture at Citizens. He has been a true enterprise leader, active in our Business Resource Groups, in helping with the startup Private Bank effort, and in mentoring our next-level leadership." As Head of Commercial Banking, McCree is responsible for all aspects of Corporate and Investment Banking, inc
Citizens Financial Group, Inc. (NYSE:CFG) today announced the appointment of Tracy A. Atkinson to the company's Board of Directors, effective March 1, 2024. Atkinson's appointment will temporarily expand the Citizens Board to 14 directors. She will serve on the Board's Audit Committee. Atkinson most recently served as an executive vice president of State Street Corporation, having held a number of senior finance and risk management roles including chief administrative officer, chief compliance officer and head of operational risk, and treasurer. "We are pleased to welcome Tracy to our board of directors," said Chairman and Chief Executive Officer Bruce Van Saun. "She brings deep financial
Citizens Financial Group, Inc. (NYSE:CFG) announced that its board of directors has declared the following dividends on its preferred stock payable on October 7, 2024, to preferred shareholders of record at the close of business on September 20, 2024: a quarterly cash dividend of $21.68547694 per share on CFG's 6.000% Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock, Series B (CUSIP No. 174610AP0); a quarterly cash dividend of $22.07475472 per share on CFG's 6.375% Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock, Series C (CUSIP No. 174610AQ8); a quarterly cash dividend of $12.50 per share ($0.3125 per each depositary share, each representing a 1/40th
Data from the casdatifan 100 mg expansion cohort of ARC-20, a Phase 1/1b study in clear cell renal cell carcinoma (ccRCC), are expected to be presented at a medical conference in the fourth quarter of 2024 PEAK-1, the initial Phase 3 study evaluating casdatifan in combination with cabozantinib, is expected to begin in the first half of 2025 Patient enrollment has completed for the Phase 3 study STAR-221 (upper gastrointestinal (GI) cancers) for domvanalimab plus zimberelimab and chemotherapy Arcus is well-positioned to advance its full pipeline with $1.0 billion in cash, cash equivalents and marketable securities and runway into 2027 Conference call today at 2:00 PM PT / 5:00 P
Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, announced that its management team will host a conference call and webcast on Thursday, August 8th, 2024 at 2 PM PT / 5 PM ET to discuss details of the Company's financial results and pipeline update for the quarter ended June 30th, 2024. Investors interested in listening to the conference call may do so by dialing (404) 975-4839 (local) or (833) 470-1428 (toll-free), using Access Code: 287576. To access the live webcast and accompanying slide presentation, please visit the "Investors & Media" section of the Arcu
Citizens Financial Group's (NYSE:CFG) short percent of float has risen 29.78% since its last report. The company recently reported that it has 12.01 million shares sold short, which is 3.53% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.51 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises. Sho
In the latest quarter, 13 analysts provided ratings for Citizens Financial Group (NYSE:CFG), showcasing a mix of bullish and bearish perspectives. The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 4 3 6 0 0 Last 30D 0 1 0 0 0 1M Ago 3 1 4 0 0 2M Ago 0 0 1 0 0 3M Ago 1 1 1 0 0 Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $41.31, along with a high estimate of $49.00 a
Stephens & Co. analyst Terry McEvoy maintains Citizens Financial Group (NYSE:CFG) with a Overweight and raises the price target from $40 to $42.
4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
4 - CITIZENS FINANCIAL GROUP INC/RI (0000759944) (Issuer)
4 - Arcus Biosciences, Inc. (0001724521) (Issuer)
4 - CITIZENS FINANCIAL GROUP INC/RI (0000759944) (Issuer)
Raymond James initiated coverage of Citizens Financial Group with a rating of Mkt Perform
Piper Sandler upgraded Citizens Financial Group from Neutral to Overweight and set a new price target of $41.00 from $35.00 previously
Citigroup upgraded Citizens Financial Group from Neutral to Buy and set a new price target of $36.00